# CCB Equity

> CCB Equity is a VC fund backing Manufacturing, Health Care and Medical. See 11 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 11
- Last investment: Jul 2026
- Lead investor: 27%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/china-construction-bank
- Website: http://group3.ccb.com/cn/group/include/20211120_1637414771.html

CCB Equity is a professional subsidiary of China Construction Bank engaged in private equity investment business dedicated to the management of national strategic emerging industry development funds (hereinafter referred to as "Zhanxin Fund") and other private equity funds.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Manufacturing | 5 | 45% |
| Health Care | 3 | 27% |
| Medical | 2 | 18% |
| Software | 2 | 18% |
| Advanced Materials | 2 | 18% |

24 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 4 | 36% |
| Series A | 2 | 18% |
| Series C | 2 | 18% |
| Venture - Series Unknown | 2 | 18% |
| Debt Financing | 1 | 9% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Aixin Semiconductor Technology | Aixin Semiconductor Technology specializes in the research and development, manufacturing, and sales of semiconductor front-end measurement and testing equipment. It has a production plant of more than 1,000 square meters in Shenzhen, including a thousand-level assembly and commissioning clean room, and a hundred-level, and ten-level laboratoryclean room. |  | Series B | Jul 20, 2026 |  |
| Boardstone Intelligence | Boardstone Intelligence is a provider of precision 3D inspection solutions and laboratory analysis solutions. |  | Series B | Mar 04, 2026 |  |
| Hualu New Materials | Hualu New Materials is a subsidiary of China National Chemical Engineering Group Corporation, focusing on the research, development, and industrial application of advanced new materials, and leveraging the group’s strong engineering capabilities and resources to support innovation in chemical engineering, manufacturing, and infrastructure projects. |  | Series A | Jan 06, 2026 |  |
| AECC Commercial Aircraft Engine | AECC offers design, development, production, assembly, testing, and technical consulting of commercial aircraft power services. |  | Series A | Jun 06, 2025 |  |
| Sonosemi Medical | Sonosemi Medical is a provider of medical devices that specializes in the development of pan-vascular active interventional products, diagnosis, and treatment solutions. | $27.3M | Series B | Oct 26, 2023 |  |
| Care Medical | Care Medical is a membrane science platform that focuses on blood purification and biopharmaceuticals. | $13.6M | Series C | Sep 08, 2023 |  |
| Fullcryo | Fullcryo provides solutions for helium extraction from natural gas, hydrogen liquefaction, and liquefied hydrogen storage. | $111.7M | Series C | Aug 03, 2023 |  |
| Jiemeng Intelligence | Jiemeng Intelligence is a provider, developer, and manufacturing of lithium-ion battery coating equipment. The company focuses on front-end equipment development, design, and manufacture, as well as lithium-ion battery machinery, to provide clients with safe, efficient, and smart new energy equipment solutions. |  | Venture - Series Unknown | Aug 01, 2023 |  |
| OptoMedic | OptoMedic is specializing in the research and development and production of high-end optical medical devices and systems. |  | Debt Financing | Jul 12, 2023 |  |
| Shanghai Desano Pharmaceuticals Investment | Desino was founded in 1996 and is headquartered in Shanghai Zhangjiang Hi-Tech Park. The company's anti-AIDS drugs and anti-malarial drugs are the core development areas for the global public health crisis, and are committed to the development, production, registration and global sales of high-quality drugs.The Dyson Company R&D Center islocated in Shanghai and is the National Enterprise Technology Center, the National Anti-AIDS Drug Engineering Technology Research Center and the National Postdoctoral Research Station. |  | Venture - Series Unknown | Feb 02, 2023 |  |

10 of 11 investments shown.

## Co-investors
- Chengtong Mixed Reform — VC Fund, 2 deals together
- [Guangzhou Yuexiu Industrial Investment Fund](https://shizune.co/investors/profile/guangzhou-yuexiu-industrial-investment-fund) — VC Fund, 2 deals together
- [Oriza Holdings](https://shizune.co/investors/profile/oriza-holdings) — VC Fund, 2 deals together
- [Alwin Capital](https://shizune.co/investors/profile/alwin-capital) — VC Fund, 1 deal together
- [Aviation Development Fund](https://shizune.co/investors/profile/aviation-development-fund) — VC Fund, 1 deal together
- [Beijing E-town International Investment & Development](https://shizune.co/investors/profile/beiid) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does CCB Equity invest in?

CCB Equity invests primarily in Manufacturing, Health Care and Medical startups, most often at Series B and Series A stage. Most of the 11 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did CCB Equity last invest?

The most recent investment recorded for CCB Equity closed in Jul 2026. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co